Works matching AU Januszewicz, E

Results: 25

A multicentre retrospective comparison of central nervous system prophylaxis strategies among patients with high-risk diffuse large B-cell lymphoma.

Published in:

British Journal of Cancer, 2014, v. 111, n. 6, p. 1072, doi. 10.1038/bjc.2014.405

By:

Cheah, C Y;
Herbert, K E;
O'Rourke, K;
Kennedy, G A;
George, A;
Fedele, P L;
Gilbertson, M;
Tan, S Y;
Ritchie, D S;
Opat, S S;
Prince, H M;
Dickinson, M;
Burbury, K;
Wolf, M;
Januszewicz, E H;
Tam, C S;
Westerman, D A;
Carney, D A;
Harrison, S J;
Seymour, J F

Publication type:

Article

Fludarabine based combinations are highly effective as first-line or salvage treatment in patients with Waldenström macroglobulinemia.

Published in:

Leukemia & Lymphoma, 2010, v. 51, n. 12, p. 2188, doi. 10.3109/10428194.2010.524326

By:

Peinert, Stefan;
Tam, Constantine S.;
Prince, H. Miles;
Scarlett, John;
Wolf, Max M.;
Januszewicz, E. Henry;
Westerman, David;
Seymour, John F.

Publication type:

Article

Cardiovascular toxicity is increased, but manageable, during high-dose chemotherapy and autologous peripheral blood stem cell transplantation for patients aged 60 years and older.

Published in:

Leukemia & Lymphoma, 2005, v. 46, n. 11, p. 1575, doi. 10.1080/10428190500235884

By:

Mileshkin, L. R.;
Seymour, J. F.;
Wolf, M. M.;
Gates, P.;
Januszewicz, E. H.;
Joyce, P.;
Prince, H. M.

Publication type:

Article

A phase II study of liposomal doxorubicin, vincristine and dexamethasone in multiple myeloma.

Published in:

2005

By:

Hönemann, Dirk;
Prince, H. Miles;
Seymour, John F.;
Wolf, Max M.;
Westerman, David;
Januszewicz, E. Henry

Publication type:

Letter

Hypercalcemia Complicating Myelomonoblastic Transformation of Chronic Myeloid Leukemia.

Published in:

Acta Haematologica, 1988, v. 79, n. 4, p. 211, doi. 10.1159/000205810

By:

Attar, E.;
Prokocimer, M.;
Januszewicz, E.;
Theodor, E.

Publication type:

Article

A Therapeutic Trial with Low-Dose Cytarabine in Myelodysplastic Syndromes and Acute Leukemia.

Published in:

Acta Haematologica, 1985, v. 73, n. 2, p. 71, doi. 10.1159/000206283

By:

Inbal, A.;
Januszewicz, E.;
Rabinowictz, M.;
Shaklai, M.

Publication type:

Article

High‐dose chemotherapy with busulphan and cyclophosphamide and bone‐marrow transplantation for drug‐sensitive malignancies in adults: a preliminary report.

Published in:

Medical Journal of Australia, 1989, v. 151, n. 7, p. 379, doi. 10.5694/j.1326-5377.1989.tb101219.x

By:

Sheridan, William P.;
Boyd, Andrew W.;
Green, Michael D.;
Russell, David M.R.;
Thomas, Robert J.S.;
McGrath, Katherine M.;
Vaughan, Stephen L.;
Scarlett, John D.;
Griffiths, James D.;
Brodie, Graeme N.;
Januszewicz, E. Henry;
Fox, Richard M.

Publication type:

Article

Dose-reduced fludarabine, cyclophosphamide and rituximab is well tolerated in older patients with chronic lymphocytic leukemia and has preserved therapeutic efficacy.

Published in:

Leukemia & Lymphoma, 2016, v. 57, n. 5, p. 1044, doi. 10.3109/10428194.2015.1096353

By:

Lew, Thomas E.;
Cheah, Chan Y.;
Carney, Dennis A.;
Prince, H. Miles;
Wolf, Max;
Bazargan, Ali;
Januszewicz, E. Henry;
Filshie, Robin;
Westerman, David;
Seymour, John F.;
Tam, Constantine S.

Publication type:

Article

P83 FAs mediate cardiac hypertrophic response to exercise.

Published in:

Cardiovascular Research, 2014, v. 103, n. suppl_1, p. S14, doi. 10.1093/cvr/cvu082.26

By:

Brix, S;
Foryst-Ludwig, A;
Salatzki, J;
Januszewicz, E;
Rothe, M;
Kershaw, E;
Kintscher, U

Publication type:

Article

Fludarabine combinations for patients with advanced marginal zone lymphomas – best treatment option or too toxic?

Published in:

2009

By:

Peinert, Stefan;
Carney, Dennis;
Miles Prince, H.;
Henry Januszewicz, E.;
Seymour, John F.

Publication type:

Letter

Inhibition of normal human macrophage progenitors by retinoic acid.

Published in:

British Journal of Haematology, 1984, v. 58, n. 1, p. 119, doi. 10.1111/j.1365-2141.1984.tb06066.x

By:

Januszewicz, E.;
Cooper, I. A.

Publication type:

Article

Repetitive high-dose therapy with cyclophosphamide, thiotepa and docetaxel with peripheral blood progenitor cell and filgrastim support for metastatic and locally advanced breast cancer: results of a phase I study.

Published in:

Bone Marrow Transplantation, 2000, v. 26, n. 9, p. 955, doi. 10.1038/sj.bmt.1702650

By:

Prince, H M;
Rischin, D;
Toner, G C;
Seymour, J F;
Blakey, D;
Gates, P;
Eerhard, S;
Chapple, P;
Quinn, M;
Brettell, M;
Juneja, S;
Wolf, M;
Januszewicz, E H;
Richardson, G;
Scarlett, J;
Briggs, P

Publication type:

Article

Docetaxel effectively mobilizes peripheral blood CD34<sup>+</sup> cells.

Published in:

Bone Marrow Transplantation, 2000, v. 26, n. 5, p. 483, doi. 10.1038/sj.bmt.1702540

By:

Prince, H M;
Toner, G C;
Seymour, J F;
Blakey, D;
Gates, P;
Eerhard, S;
Chapple, P;
Wall, D;
Quinn, M;
Juneja, S;
Wolf, M;
Januszewicz, E H;
Richardson, G;
Scarlett, J;
Briggs, P;
Brettell, M;
Rischin, D

Publication type:

Article

Ifosfamide in combination with paclitaxel or doxorubicin: regimens which effectively mobilize peripheral blood progenitor cells while demonstrating anti-tumor activity in patients with metastatic breast cancer.

Published in:

Bone Marrow Transplantation, 1999, v. 23, n. 5, p. 427, doi. 10.1038/sj.bmt.1701606

By:

Prince, H M;
Gardyn, J;
Millward, M J;
Rischin, D;
Francis, P;
Gates, P;
Chapple, P;
Quinn, M;
Juneja, S;
Wolf, M;
Januszewicz, E H;
Richardson, G;
Scarlett, J;
Briggs, P;
Brettell, M;
Toner, G C

Publication type:

Article

Emergence of central nervous system myeloma in the era of novel agents.

Published in:

Hematological Oncology, 2012, v. 30, n. 4, p. 170, doi. 10.1002/hon.1021

By:

Gangatharan, Shane A;
Carney, Dennis A;
Prince, H Miles;
Wolf, Max M;
Januszewicz, E Henry;
Ritchie, David S;
Harrison, Simon J

Publication type:

Article

Requirements for growth of human erythroid progenitors in nutrient agar.

Published in:

American Journal of Hematology, 1983, v. 15, n. 3, p. 207, doi. 10.1002/ajh.2830150302

By:

Januszewicz, E.;
Cooper, I. A.;
Bradley, T. R.

Publication type:

Article

High-dose therapy and autologous transplantation for lymphoma: The Peter MacCallum Cancer Institute experience.

Published in:

Internal Medicine Journal, 2001, v. 31, n. 5, p. 279, doi. 10.1046/j.1445-5994.2001.00066.x

By:

Dowling, A. J.;
Prince, H. M.;
Wirth, A.;
Wolf, M.;
Januszewicz, E. H.;
Juneja, S.;
Seymour, J. F.;
Gates, P.;
Smith, J. G.

Publication type:

Article

Therapy-related myelodysplastic syndrome and acute myeloid leukemia following fludarabine combination chemotherapy.

Published in:

Leukemia (08876924), 2010, v. 24, n. 12, p. 2056, doi. 10.1038/leu.2010.218

By:

Carney, D. A.;
Westerman, D. A.;
Tam, C. S.;
Milner, A.;
Prince, H. M.;
Kenealy, M.;
Wolf, M.;
Januszewicz, E. H.;
Ritchie, D.;
Came, N.;
Seymour, J. F.

Publication type:

Article

Predictive factors for successful stem cell mobilization in patients with indolent lymphoproliferative disorders previously treated with fludarabine.

Published in:

2004

By:

Morgan, S. J.;
Seymour, J. F.;
Grigg, A.;
Matthews, J. P.;
Prince, H. M.;
Wolf, M. M.;
Januszewicz, E. H.

Publication type:

Letter

Hodgkin's disease type Richter's syndrome in chronic lymphocytic leukemia.

Published in:

1999

By:

Juneja, S;
Carney, D;
Ellis, D;
Januszewicz, E H;
Wolf, M;
Prince, H M

Publication type:

Case Study

The influence of increasing age on the deliverability and toxicity of fludarabine-based combination chemotherapy regimens in patients with indolent lymphoproliferative disorders.

Published in:

Cancer (0008543X), 2006, v. 107, n. 4, p. 773, doi. 10.1002/cncr.22022

By:

Polizzotto, Mark N.;
Tam, Constantine S.;
Milner, Alvin;
Januszewicz, E. Henry;
Prince, H. Miles;
Westerman, David;
Wolf, Max M.;
Seymour, John F.

Publication type:

Article

Fludarabine, cyclophosphamide, and rituximab for the treatment of patients with chronic lymphocytic leukemia or indolent non‐hodgkin lymphoma.

Published in:

Cancer (0008543X), 2006, v. 106, n. 11, p. 2412

By:

Constantine S. Tam;
Max Wolf;
H. Miles Prince;
E. Henry Januszewicz;
David Westerman;
Katherine I. Lin;
Dennis Carney;
John F. Seymour

Publication type:

Article

A new model for predicting infectious complications during fludarabine‐based combination chemotherapy among patients with indolent lymphoid malignancies.

Published in:

Cancer (0008543X), 2004, v. 101, n. 9, p. 2042

By:

Constantine S. Tam;
Max M. Wolf;
E. Henry Januszewicz;
Andrew P. Grigg;
H. Miles Prince;
David Westerman;
John F. Seymour

Publication type:

Article

Fludarabine and cyclophosphamide using an attenuated dose schedule is a highly effective regimen for patients with indolent lymphoid malignancies.

Published in:

Cancer (0008543X), 2004, v. 100, n. 10, p. 2181

By:

Constantine S. Tam;
Max M. Wolf;
E. Henry Januszewicz;
H. Miles Prince;
David Westerman;
John F. Seymour

Publication type:

Article

Fludarabine Combination Therapy Is Highly Effective in First-Line and Salvage Treatment of Patients with Waldenström's Macroglobulinemia.

Published in:

Clinical Lymphoma & Myeloma, 2005, v. 6, n. 2, p. 136

By:

Tam, Constantine S.;
Wolf, Max M.;
Westerman, David;
Januszewicz, E. Henry;
Prince, H. Miles;
Seymour, John F.

Publication type:

Article